Literature DB >> 33954019

Dermoscopic Features as Predictors of BRAF Mutational Status and Sentinel Lymph Node Positivity in Primary Cutaneous Melanoma.

Nika Filipović1, Mirna Šitum1,2, Marija Buljan1,2.   

Abstract

Dermoscopy is a diagnostic tool widely used in clinical practice for the detection of skin tumors, especially early stages of melanoma. Recent studies have shown that different dermoscopic features are associated with important prognostic parameters of melanoma, such as BRAF mutational status and sentinel lymph node status. More than half of all melanomas harbor a mutation in the BRAF oncogene. The current management of advanced-stage melanomas is greatly determined by the presence or absence of a mutation in this gene, as targeted therapy with BRAF kinase inhibitors is one of the first therapeutic choices for these patients. Sentinel lymph node status is one of the most significant predictors of a melanoma patient's survival. Recent studies have shown that different dermoscopic patterns are also associated with sentinel lymph node status. This short article reviews studies that investigated correlations between dermoscopic features, BRAF mutation status and sentinel lymph node status. ©2021 Filipović et al.

Entities:  

Keywords:  BRAF; dermoscopy; melanoma; sentinel lymph node

Year:  2021        PMID: 33954019      PMCID: PMC8060001          DOI: 10.5826/dpc.1102a40

Source DB:  PubMed          Journal:  Dermatol Pract Concept        ISSN: 2160-9381


  31 in total

Review 1.  Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet.

Authors:  Giuseppe Argenziano; H Peter Soyer; Sergio Chimenti; Renato Talamini; Rosamaria Corona; Francesco Sera; Michael Binder; Lorenzo Cerroni; Gaetano De Rosa; Gerardo Ferrara; Rainer Hofmann-Wellenhof; Michael Landthaler; Scott W Menzies; Hubert Pehamberger; Domenico Piccolo; Harold S Rabinovitz; Roman Schiffner; Stefania Staibano; Wilhelm Stolz; Igor Bartenjev; Andreas Blum; Ralph Braun; Horacio Cabo; Paolo Carli; Vincenzo De Giorgi; Matthew G Fleming; James M Grichnik; Caron M Grin; Allan C Halpern; Robert Johr; Brian Katz; Robert O Kenet; Harald Kittler; Jürgen Kreusch; Josep Malvehy; Giampiero Mazzocchetti; Margaret Oliviero; Fezal Ozdemir; Ketty Peris; Roberto Perotti; Ana Perusquia; Maria Antonietta Pizzichetta; Susana Puig; Babar Rao; Pietro Rubegni; Toshiaki Saida; Massimiliano Scalvenzi; Stefania Seidenari; Ignazio Stanganelli; Masaru Tanaka; Karin Westerhoff; Ingrid H Wolf; Otto Braun-Falco; Helmut Kerl; Takeji Nishikawa; Klaus Wolff; Alfred W Kopf
Journal:  J Am Acad Dermatol       Date:  2003-05       Impact factor: 11.527

2.  The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: Significance of the blue-white veil.

Authors:  Miquel Armengot-Carbó; Eduardo Nagore; Zaida García-Casado; Rafael Botella-Estrada
Journal:  J Am Acad Dermatol       Date:  2018-01-04       Impact factor: 11.527

3.  Dermoscopic features in BRAF and NRAS primary cutaneous melanoma: association with peppering and blue-white veil.

Authors:  L Gouillon; M Perier-Muzet; M Amini-Adle; N Poulalhon; S Debarbieux; A Boespflug; B Balme; L Depaepe; O Harou; J Lopez; P-P Bringuier; C Ferraro-Peyret; D Maucort-Boulch; P Robinson; L Thomas; S Dalle
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-09-11       Impact factor: 6.166

4.  Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.

Authors:  Jeffrey E Gershenwald; Richard A Scolyer
Journal:  Ann Surg Oncol       Date:  2018-05-30       Impact factor: 5.344

Review 5.  Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma.

Authors:  Soo Young Kim; Soo Nyung Kim; Hyung Jin Hahn; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Journal:  J Am Acad Dermatol       Date:  2015-03-25       Impact factor: 11.527

6.  NCCN Guidelines Insights: Melanoma, Version 3.2016.

Authors:  Daniel G Coit; John A Thompson; Alain Algazi; Robert Andtbacka; Christopher K Bichakjian; William E Carson; Gregory A Daniels; Dominick DiMaio; Ryan C Fields; Martin D Fleming; Brian Gastman; Rene Gonzalez; Valerie Guild; Douglas Johnson; Richard W Joseph; Julie R Lange; Mary C Martini; Miguel A Materin; Anthony J Olszanski; Patrick Ott; Aparna Priyanath Gupta; Merrick I Ross; April K Salama; Joseph Skitzki; Susan M Swetter; Kenneth K Tanabe; Javier F Torres-Roca; Vijay Trisal; Marshall M Urist; Nicole McMillian; Anita Engh
Journal:  J Natl Compr Canc Netw       Date:  2016-08       Impact factor: 11.908

7.  Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis.

Authors:  J-H Lee; J-W Choi; Y-S Kim
Journal:  Br J Dermatol       Date:  2011-03-21       Impact factor: 9.302

8.  Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype.

Authors:  M C Fargnoli; F Sera; M Suppa; D Piccolo; M T Landi; A Chiarugi; C Pellegrini; S Seidenari; K Peris
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-03-04       Impact factor: 6.166

9.  The extent of whole-genome copy number alterations predicts aggressive features in primary melanomas.

Authors:  Greta Gandolfi; Caterina Longo; Elvira Moscarella; Iris Zalaudek; Valentina Sancisi; Margherita Raucci; Gloria Manzotti; Mila Gugnoni; Simonetta Piana; Giuseppe Argenziano; Alessia Ciarrocchi
Journal:  Pigment Cell Melanoma Res       Date:  2016-01-12       Impact factor: 4.693

10.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.